The incidence of DNMT3B expression was significantly higher in stage III seminomas (100%) than in stage I (35.7%) or stage II (38.5%) seminomas (P = 0.011), suggesting that such expression may reflect tumour aggressiveness. The gene discussed is DNMT3B; the disease is seminoma.